{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:17:19Z","timestamp":1791865039273,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.apsb.2024.12.005","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T17:20:01Z","timestamp":1733764801000},"page":"991-1006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A small molecule cryptotanshinone induces non-enzymatic NQO1-dependent necrosis in cancer cells through the JNK1\/2\/Iron\/PARP\/calcium pathway"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9303-284X","authenticated-orcid":false,"given":"Ying","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7617-4267","authenticated-orcid":false,"given":"Guokai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4558-3858","authenticated-orcid":false,"given":"Jose M.","family":"Martin-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2675-7645","authenticated-orcid":false,"given":"Xiuping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.12.005_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2024.12.005_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.apsb.2024.12.005_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semcancer.2019.10.019","article-title":"Current progress and future perspectives of polypharmacology: from the view of non-small cell lung cancer","volume":"68","author":"Karuppasamy","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2024.12.005_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0006-2952(94)00333-5","article-title":"Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism","volume":"49","author":"Cadenas","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2024.12.005_bib5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.apsb.2022.01.009","article-title":"Optical substrates for drug-metabolizing enzymes: recent advances and future perspectives","volume":"12","author":"Jin","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.005_bib6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.5483\/BMBRep.2015.48.11.190","article-title":"Implications of NQO1 in cancer therapy","volume":"48","author":"Oh","year":"2015","journal-title":"BMB Rep"},{"key":"10.1016\/j.apsb.2024.12.005_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbapap.2019.05.002","article-title":"NQO1: a target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms","volume":"1867","author":"Beaver","year":"2019","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.apsb.2024.12.005_bib8","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1021\/acs.jmedchem.8b00124","article-title":"NAD(P)H:quinone oxidoreductase 1 (NQO1) as a therapeutic and diagnostic target in cancer","volume":"61","author":"Zhang","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2024.12.005_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00689804","article-title":"NAD(P)H:quinone oxidoreductase 1 (DT-diaphorase) expression in normal and tumor tissues","volume":"12","author":"Belinsky","year":"1993","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.apsb.2024.12.005_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41416-018-0278-4","article-title":"Phase 1 study of ARQ 761, a \u03b2-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis","volume":"119","author":"Gerber","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.apsb.2024.12.005_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101950","article-title":"The diverse functionality of NQO1 and its roles in redox control","volume":"41","author":"Ross","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2024.12.005_bib12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.freeradbiomed.2020.03.026","article-title":"2-Methoxy-6-acetyl-7-methyljuglone (MAM) induced programmed necrosis in glioblastoma by targeting NAD(P)H:quinone oxidoreductase 1 (NQO1)","volume":"152","author":"Yu","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2024.12.005_bib13","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1158\/1078-0432.CCR-19-0302","article-title":"Bioactivation of napabucasin triggers reactive oxygen species-mediated cancer cell death","volume":"25","author":"Froeling","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2024.12.005_bib14","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1158\/0008-5472.CAN-11-3135","article-title":"An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis","volume":"72","author":"Huang","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2024.12.005_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.freeradbiomed.2021.02.014","article-title":"A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis","volume":"166","author":"Zhong","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2024.12.005_bib16","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1535-7163.MCT-12-0962","article-title":"Catalase abrogates \u03b2-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers","volume":"12","author":"Bey","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.apsb.2024.12.005_bib17","doi-asserted-by":"crossref","first-page":"19150","DOI":"10.1074\/jbc.M100730200","article-title":"Calcium is a key signaling molecule in \u03b2-lapachone-mediated cell death","volume":"276","author":"Tagliarino","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.12.005_bib18","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2007.25.18_suppl.16509","article-title":"A phase II study of ARQ 501 in patients with advanced squamous cell carcinoma of the head and neck","volume":"25","author":"Kawecki","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2024.12.005_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jso.24624","article-title":"Using a novel NQO1 bioactivatable drug, \u03b2-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer","volume":"116","author":"Beg","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.apsb.2024.12.005_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1039\/c0np00035c","article-title":"Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents","volume":"28","author":"Dong","year":"2011","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.apsb.2024.12.005_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108652","article-title":"Therapeutic potential of natural products and underlying targets for the treatment of aortic aneurysm","volume":"259","author":"Zhao","year":"2024","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2024.12.005_bib22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/med.21304","article-title":"The anticancer properties of Salvia miltiorrhiza Bunge (Danshen): a systematic review","volume":"34","author":"Chen","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2024.12.005_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.apha.2019.10.001","article-title":"Pharmacological properties of tanshinones, the natural products from Salvia miltiorrhiza","volume":"87","author":"Wang","year":"2020","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.apsb.2024.12.005_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ptr.6815","article-title":"Recent advances and future directions in anti-tumor activity of cryptotanshinone: a mechanistic review","volume":"35","author":"Ashrafizadeh","year":"2021","journal-title":"Phytother Res"},{"key":"10.1016\/j.apsb.2024.12.005_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111332","article-title":"A review of the biological activity and pharmacology of cryptotanshinone, an important active constituent in Danshen","volume":"137","author":"Li","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2024.12.005_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2020.104633","article-title":"Cryptotanshinone: a review of its pharmacology activities and molecular mechanisms","volume":"145","author":"Wu","year":"2020","journal-title":"Fitoterapia"},{"key":"10.1016\/j.apsb.2024.12.005_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2174\/1871520615666150907093036","article-title":"Cryptotanshinone induces pro-death autophagy through JNK signaling mediated by reactive oxygen species generation in lung cancer cells","volume":"16","author":"Hao","year":"2016","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.apsb.2024.12.005_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2023.03.020","article-title":"Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction","volume":"202","author":"Xiao","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2024.12.005_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105870","article-title":"Nannocystin ax, an eEF1A inhibitor, induces G1 cell cycle arrest and caspase-independent apoptosis through cyclin D1 downregulation in colon cancer in\u00a0vivo","volume":"173","author":"Hou","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2024.12.005_bib30","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0006-3495(01)76183-8","article-title":"Mechanisms of tryptophan fluorescence shifts in proteins","volume":"80","author":"Vivian","year":"2001","journal-title":"Biophys J"},{"key":"10.1016\/j.apsb.2024.12.005_bib31","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2024.12.005_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2024.12.005_bib33","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"10.1016\/j.apsb.2024.12.005_bib34","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2024.12.005_bib35","article-title":"Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2024.12.005_bib36","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2174\/18715206113139990115","article-title":"Molecular evidence of cryptotanshinone for treatment and prevention of human cancer","volume":"13","author":"Chen","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.apsb.2024.12.005_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0969-2126(01)00636-0","article-title":"Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones","volume":"9","author":"Faig","year":"2001","journal-title":"Structure"},{"key":"10.1016\/j.apsb.2024.12.005_bib38","article-title":"Endoplasmic reticulum stress-induced JNK activation is a critical event leading to mitochondria-mediated cell death caused by \u03b2-lapachone treatment","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2024.12.005_bib39","first-page":"4134","article-title":"PARP1-mediated necrosis is dependent on parallel JNK and Ca2+\/calpain pathways","volume":"127","author":"Douglas","year":"2014","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2024.12.005_bib40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/biology10030184","article-title":"Lipid metabolism and ferroptosis","volume":"10","author":"Lee","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.apsb.2024.12.005_bib41","doi-asserted-by":"crossref","first-page":"33684","DOI":"10.1074\/jbc.M603678200","article-title":"Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair","volume":"281","author":"Bentle","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.12.005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100977","article-title":"Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis","volume":"70","author":"Yu","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.apsb.2024.12.005_bib43","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/acs.accounts.5b00365","article-title":"Deoxynyboquinones as NQO1-activated cancer therapeutics","volume":"48","author":"Parkinson","year":"2015","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.apsb.2024.12.005_bib44","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.7150\/ijbs.31277","article-title":"Cryptotanshinone suppresses non-small cell lung cancer via microRNA-146a-5p\/EGFR axis","volume":"15","author":"Qi","year":"2019","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.apsb.2024.12.005_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.biopha.2016.05.015","article-title":"Cryptotanshinone induces melanoma cancer cells apoptosis via ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion","volume":"82","author":"Ye","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2024.12.005_bib46","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/DDDT.S132488","article-title":"Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2\/STAT3 and PI3K\/Akt\/NF\u03baB pathways in cholangiocarcinoma cells","volume":"11","author":"Ke","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.apsb.2024.12.005_bib47","doi-asserted-by":"crossref","first-page":"115398","DOI":"10.18632\/oncotarget.23267","article-title":"Cryptotanshinone induces ROS-mediated apoptosis in human gastric cancer cells","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2024.12.005_bib48","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.tiv.2008.02.013","article-title":"A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker","volume":"22","author":"Cho","year":"2008","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.apsb.2024.12.005_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-385493-3.00004-8","article-title":"Apoptosis and beyond: cytometry in studies of programmed cell death","volume":"103","author":"Wlodkowic","year":"2011","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.apsb.2024.12.005_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107593","article-title":"Induction of programmed necrosis: a novel anti-cancer strategy for natural compounds","volume":"214","author":"Yu","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2024.12.005_bib51","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/j.apsb.2024.04.020","article-title":"Therapeutic strategies\u00a0of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer","volume":"14","author":"Jin","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.005_bib52","doi-asserted-by":"crossref","first-page":"18203","DOI":"10.1074\/jbc.M117.813923","article-title":"The NQO1 bioactivatable drug, \u03b2-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism","volume":"292","author":"Silvers","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.12.005_bib53","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1039\/D3LC00176H","article-title":"Modular droplet injector for sample conservation providing new structural insight for the conformational heterogeneity in the disease-associated NQO1 enzyme","volume":"23","author":"Doppler","year":"2023","journal-title":"Lab Chip"},{"key":"10.1016\/j.apsb.2024.12.005_bib54","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/1873-3468.14738","article-title":"Structural dynamics at the active site of the cancer-associated flavoenzyme NQO1 probed by chemical modification with PMSF","volume":"597","author":"Grieco","year":"2023","journal-title":"FEBS Lett"},{"key":"10.1016\/j.apsb.2024.12.005_bib55","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1073\/pnas.0702176104","article-title":"An NQO1-and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by \u03b2-lapachone","volume":"104","author":"Bey","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.apsb.2024.12.005_bib56","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2024.12.005_bib57","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ccell.2016.11.006","article-title":"Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly(ADP-ribose) polymerase inhibitors","volume":"30","author":"Huang","year":"2016","journal-title":"Cancer Cell"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524004623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524004623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T11:40:18Z","timestamp":1741693218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524004623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2211383524004623"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.12.005","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A small molecule cryptotanshinone induces non-enzymatic NQO1-dependent necrosis in cancer cells through the JNK1\/2\/Iron\/PARP\/calcium pathway","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}